| INTERESTING CASES |
|
| Year : 2021 | Volume
: 20
| Issue : 3 | Page : 324-326 |
|
|
Somatostatin-receptor avidity of pancreatic neuroendocrine tumor thrombus in porto-caval venous systems on 99mTc-Octreotide and posttherapeutic 177Lu-DOTA-TATE scans
Mahasti Amoui1, Reyhane Ahmadi2, Mohsen Qutbi1, Isa Neshandar Asli1
1 Department of Nuclear Medicine, School of Medicine, Shahid Beheshti University of Medical sciences, Tehran, Iran
2 Department of Nuclear Medicine and Molecular Imaging, Farshchian Heart Center, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Correspondence Address:
Dr. Mohsen Qutbi
Department of Nuclear Medicine, Taleghani Hospital, Yaman Street, Velenjak, Tehran 1985711151
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/wjnm.wjnm_35_21
|
|
|
A 62-year-old woman with a history of abdominal pain presented with multiple hepatic lesions and dilatation of portal, splenic and superior mesenteric veins on the magnetic resonance imaging referred for a 99mTc-octreotide scan. Accordingly, similar octreotide-avid lesions were found as well as an uptake in the epigastric region conforming to the anatomy of the portocaval venous system, compatible with a tumor thrombosis. Then, the patient underwent two cycles of therapy with 177Lu-DOTA-TATE, on that the same appearance was observed. The uptake in the tumor thrombus remained somewhat unchanged, but clinically, a significant improvement of the intractable ascites was achieved. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Users Online: 461 
